Reteplase: A promising alternative in acute ischemic stroke management

Neurosurg Rev. 2024 Jul 31;47(1):379. doi: 10.1007/s10143-024-02642-3.
No abstract available

Publication types

  • Editorial
  • Letter

MeSH terms

  • Brain Ischemia / drug therapy
  • Fibrinolytic Agents* / therapeutic use
  • Humans
  • Ischemic Stroke* / drug therapy
  • Recombinant Proteins / therapeutic use
  • Stroke / drug therapy
  • Tissue Plasminogen Activator* / therapeutic use

Substances

  • Tissue Plasminogen Activator
  • Fibrinolytic Agents
  • reteplase
  • Recombinant Proteins